Skip to main content
. 2023 Jan 20;14:1084630. doi: 10.3389/fimmu.2023.1084630

Figure 3.

Figure 3

Positive serology and ELISpot indexes in cases and controls during the long-term phase post-SARS-CoV-2 infection. (A) Positive and negative SARS-CoV-2 specific IgG+, IgM+, and IgA+ are represented in the bars for IEI patients and controls. Only statistically significant differences are shown (*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001). (B) S-ELISpot index comparison in cases-controls during the long-term period after the infection. There are two extreme values that are not represented in the box-plot graphic: ELISpot index for a control at 4-6 weeks: 63; ELISpot index at 6 months for P15: 48. (C) N-ELISpot index in cases and controls during the long-term follow-up. For (B, C)the box horizontal middle line represents the median, the extremes represent lower quartile (Q1) and higher quartile (Q3); maximum and minimum values (without outliers) are represented by the horizontal lines in the extremes of the whiskers. The individual values between quartile 1 and 3 are represented by dots; the mean is represented by an “x” symbol. For all panels significance levels are marked as *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001, ns: p>0.05.